New hope for pancreatic cancer: experimental drug combo enters human trials
Disease control
Recruiting now
This early-phase trial is testing whether adding two experimental drugs (KN510 and KN713) to standard chemotherapy (mFOLFIRINOX) is safe and effective for people with advanced pancreatic cancer that cannot be removed by surgery. About 30 adults aged 19–75 who have not had prior c…
Phase: PHASE1, PHASE2 • Sponsor: New Cancer Cure-Bio Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC